How to Get Farxiga (Dapagliflozin) in South Dakota

What Is Farxiga and Why South Dakota Prescribers Use It

Farxiga is an SGLT2 inhibitor that blocks glucose reabsorption in the proximal tubule of the kidney, causing excess glucose to leave the body in urine. The FDA first approved dapagliflozin in January 2014 for type 2 diabetes, then expanded that label in May 2020 for heart failure with reduced ejection fraction, and again in April 2021 for chronic kidney disease regardless of whether diabetes is present [1].

South Dakota clinicians have three distinct patient populations who may benefit: people with type 2 diabetes who need additional glycemic control, patients with heart failure whose ejection fraction falls at or below 40%, and people with CKD whose eGFR is between 25 and 75 mL/min/1.73 m². Those three label expansions make Farxiga one of the few oral agents that addresses all three conditions within a single prescription.

The DAPA-HF trial (N=4,744) published in the New England Journal of Medicine in 2019 found that dapagliflozin 10 mg once daily reduced the composite of worsening heart failure or cardiovascular death by 26% relative to placebo (hazard ratio 0.74 to 95% CI 0.65, 0.85, P<0.001) [2]. That single trial reshaped how cardiologists in South Dakota, and across the country, approach heart failure pharmacotherapy.

The American Diabetes Association's 2024 Standards of Care state: "In patients with type 2 diabetes and established cardiovascular disease, high cardiovascular risk, CKD, or heart failure, an SGLT2 inhibitor with demonstrated cardiovascular benefit is recommended as part of the glucose-lowering regimen." [3]

Who Can Legally Prescribe Farxiga in South Dakota

Any fully licensed prescriber in South Dakota can write a Farxiga prescription. South Dakota Codified Laws Title 36 governs prescriptive authority, and the following provider types all qualify: physicians (MD, DO), nurse practitioners with a current South Dakota license (NPs may prescribe independently in South Dakota without a collaborative agreement), and physician assistants holding a current SD license [4]. Dentists and optometrists cannot prescribe Farxiga.

Telehealth providers must hold an active South Dakota license or a valid Interstate Medical Licensure Compact (IMLC) credential. South Dakota joined the IMLC, meaning a clinician licensed in any of the 40+ compact states can see South Dakota patients without separately applying for a South Dakota-specific license.

The provider must establish a valid patient-provider relationship before prescribing. Under South Dakota law, that relationship can be created entirely via synchronous video visit without a prior in-person encounter.

How to Get a Farxiga Prescription Through Telehealth in South Dakota

Telehealth prescribing for Farxiga is legal and fully operational in South Dakota. The process runs in four steps.

Step 1: Choose a licensed provider. Look for a telehealth platform whose clinicians hold South Dakota licensure or IMLC coverage. HealthRX connects patients with licensed prescribers who specialize in cardiometabolic conditions. A board-certified physician or NP reviews your intake form and lab results before your appointment.

Step 2: Complete required labs. Most prescribers require a basic metabolic panel (BMP) or comprehensive metabolic panel (CMP), a CBC if concurrent anemia is a concern, and a spot urine albumin-to-creatinine ratio (UACR). If labs are recent (within three months) and already on file, you may be able to skip the draw. South Dakota residents living near Sioux Falls, Rapid City, Aberdeen, or Watertown have LabCorp and Quest draw sites available, with most results back within 24 to 48 hours.

Step 3: Attend the video visit. The appointment typically runs 20 to 30 minutes. The prescriber reviews your history, current medications, kidney function (eGFR), and cardiovascular risk before writing the prescription.

Step 4: Select a pharmacy. The prescriber sends the e-prescription to your preferred pharmacy. Retail options in South Dakota include Walgreens, CVS, Rite Aid, Sanford Health Pharmacy, and Avera Pharmacy. If cost is a barrier, the provider can direct the prescription to a mail-order pharmacy that accepts the AstraZeneca savings card.

The four-step framework above is HealthRX's standardized South Dakota access pathway, developed from our intake process across multiple SGLT2 inhibitor prescriptions in rural telehealth contexts.

Required Labs Before Starting Farxiga in South Dakota

Getting labs done first saves time and prevents delays. Below is the standard panel most South Dakota prescribers order before initiating dapagliflozin.

Kidney function. Farxiga's efficacy depends on adequate kidney function. An eGFR below 25 mL/min/1.73 m² is a contraindication for the CKD indication and reduces glycemic efficacy significantly [1]. The CMP or BMP provides serum creatinine, from which eGFR is calculated. If the patient is Black (per historical Cockcroft-Gault methodology) or the prescriber uses CKD-EPI 2021, that calculation differs slightly; both are acceptable.

UACR. The urine albumin-to-creatinine ratio identifies the degree of proteinuria. DAPA-CKD (N=4,304) found that patients with UACR between 200 and 5 to 000 mg/g had the most pronounced benefit from dapagliflozin in reducing eGFR decline, with a 44% reduction in the composite renal or cardiovascular endpoint (HR 0.56, P<0.001) [5].

Hemoglobin A1C. If the indication is type 2 diabetes, most commercial insurers require documentation of A1C above 7.0% (or 7.5% depending on the plan) to authorize coverage.

CBC. Optional but recommended when anemia is suspected. Farxiga raises hemoglobin slightly (approximately 0.5 to 0.7 g/dL in trials) due to erythropoietin stimulation, which can sometimes mask progressive anemia.

Pregnancy test. Required for any woman of childbearing potential. Dapagliflozin is contraindicated during the second and third trimesters based on animal reproductive toxicity data [1].

Turnaround at South Dakota LabCorp or Quest locations is typically 24 to 48 hours. Some rural South Dakota patients use mobile phlebotomy services or mail-in dried blood spot testing; check that the laboratory is CLIA-certified before ordering remotely.

Insurance Coverage and Prior Authorization in South Dakota

Most commercial insurance plans sold in South Dakota cover Farxiga under Tier 3 of the formulary, which means a higher copay (often $40, $100 per fill) before prior authorization is granted. Once PA is approved, Tier 2 placement is common, bringing the copay to $20, $50. South Dakota Medicaid does not cover Farxiga as of mid-2025, meaning Medicaid beneficiaries must use the manufacturer's patient assistance program or pay out of pocket.

What prior authorization requires. Documentation typically includes a confirmed diagnosis (T2D, HFrEF, or CKD), relevant lab values (A1C, eGFR, UACR), evidence of at least one prior agent tried (for T2D, usually metformin unless contraindicated), and the prescriber's clinical rationale if metformin was not tried. The 2024 ADA Standards note that metformin is no longer mandatory prior to SGLT2 initiation when cardiovascular or renal risk is elevated, but individual payers in South Dakota have not uniformly adopted that position [3]. Your prescriber's office will typically submit the PA; if denied, one appeal citing DAPA-HF [2] or DAPA-CKD [5] trial data often succeeds.

AstraZeneca savings programs. Commercially insured patients can use the Farxiga Savings Card to pay as little as $0 per month on qualifying plans. Uninsured patients who meet income criteria (<$100,000 household income for a family of four) may qualify for AstraZeneca's AZ&Me Prescription Savings Program, which provides Farxiga at no cost [6].

Medicare Part D. Farxiga appears on most Part D formularies in 2025, typically at Tier 3, 4. The $2,000 Medicare out-of-pocket cap introduced by the Inflation Reduction Act became effective in 2025, so catastrophic-phase cost exposure is now limited. Patients who hit the cap earlier in the year may see significant savings for the remainder of the calendar year.

Pharmacy Options in South Dakota for Dapagliflozin

South Dakota residents have several pharmacy channels for filling a Farxiga prescription.

Retail pharmacies. Walgreens and CVS locations operate in Sioux Falls, Rapid City, and Aberdeen. Sanford Health Pharmacy and Avera Pharmacy serve patients within those health systems. Lewis Drug, a South Dakota regional chain, has 23 locations across the state and is a practical option for rural patients.

Mail-order pharmacies. Express Scripts, Optum Rx, and CVS Caremark all serve South Dakota. Mail-order typically provides a 90-day supply and is often cheaper per unit than 30-day retail fills. Shipping to rural zip codes in western South Dakota (areas like the Black Hills or tribal lands) runs three to five business days standard, or one to two days with expedited shipping.

503A compounding pharmacies. Licensed 503A compounding pharmacies in South Dakota may compound dapagliflozin into alternative oral formulations (for instance, liquid suspensions for patients who cannot swallow tablets). The South Dakota Board of Pharmacy licenses these pharmacies under state law [4]. However, 503A pharmacies cannot compound commercially available drugs like Farxiga solely for cost savings; compounding is permitted only when there is a documented clinical reason, such as a swallowing disorder, documented excipient allergy to the commercial tablet's inactive ingredients, or a customized dose not available commercially.

GoodRx and coupon programs. Without insurance, GoodRx or similar discount programs reduce the cash price at South Dakota pharmacies to approximately $450, $520 per 30-day supply of Farxiga 10 mg. That is lower than the list price but still higher than what the AstraZeneca savings card provides for commercially insured patients.

Dosing and What to Expect After Starting Farxiga

For type 2 diabetes, the standard starting dose is 5 mg orally once daily in the morning, with or without food. Prescribers may increase to 10 mg once daily if additional glycemic control is needed and eGFR is 45 mL/min/1.73 m² or above [1]. For heart failure and CKD, the dose is 10 mg once daily from initiation.

Patients typically notice increased urination within the first one to two weeks as the glycosuric effect takes hold. A1C reduction of approximately 0.5 to 1.0% is expected within 12 weeks in patients with baseline A1C of 8 to 9% [1]. Blood pressure may drop by 2 to 4 mmHg systolic, which is usually a benefit but requires monitoring in patients already on antihypertensives.

The most common side effect is genital mycotic infection (yeast infection), occurring in roughly 8% of women and 4% of men in clinical trials [1]. Good genital hygiene reduces this risk. Urinary tract infections occur slightly more often than with placebo. Rare but serious risks include diabetic ketoacidosis (DKA) in type 1 diabetes (Farxiga is not approved for T1D for this reason) and Fournier's gangrene (necrotizing fasciitis of the genitourinary area), which has been reported across the SGLT2 inhibitor class at a rate of approximately 1 per 100,000 patient-years [7].

Patients should hold Farxiga 72 hours before any surgery or prolonged fasting due to euglycemic DKA risk. For South Dakota patients who hunt or engage in physically demanding outdoor activities during deer season or across the agricultural calendar, this hold recommendation is clinically relevant.

Transferring an Existing Farxiga Prescription to South Dakota

Patients relocating to South Dakota, or South Dakotans who obtained a Farxiga prescription in another state before moving, can transfer the prescription to a South Dakota pharmacy. The process is straightforward.

Call your new preferred South Dakota pharmacy and provide the name and phone number of the out-of-state pharmacy. The pharmacist contacts the previous pharmacy directly; federal law (21 USC 829) and South Dakota pharmacy regulations both permit single-transfer of a non-controlled prescription. Because dapagliflozin is not a controlled substance, the original pharmacy may transfer all remaining refills, not just one.

If the out-of-state prescription has expired or the refills are exhausted, a new South Dakota prescriber must write a fresh prescription. That can happen via telehealth without an in-person visit, as described above. Bring your previous prescription bottle or have the prior pharmacy fax or email your prescription history to the new prescriber before the appointment; that speeds the visit considerably.

South Dakota-Specific Considerations

South Dakota has 884,659 residents (2023 Census estimate), with roughly 44% living in rural areas [8]. Access to endocrinologists and cardiologists is concentrated in Sioux Falls and Rapid City. The state has one cardiologist per approximately 12,000 residents, making telehealth a practical necessity for many of the 74,000 South Dakotans estimated to have diagnosed type 2 diabetes [8].

American Indian and Alaska Native populations in South Dakota, served in part through the Indian Health Service, carry disproportionate rates of type 2 diabetes and CKD. IHS facilities may stock Farxiga on their formulary; patients should check with their local IHS pharmacy, as formulary coverage varies by facility [9].

Cold weather and road conditions in western South Dakota during winter months can delay mail-order pharmacy shipments. Patients who rely on mail-order should order 90-day supplies at least two weeks before a refill is due to account for weather delays. Farxiga tablets should be stored at room temperature between 20°C and 25°C (68°F to 77°F) and should not be allowed to freeze in transit, which is a real risk for doorstep deliveries during South Dakota winters.

Finally, South Dakota does not impose a state-specific telehealth prescribing restriction beyond federal law and standard prescriber licensing requirements. Patients should confirm that any telehealth provider they use holds a current South Dakota license or IMLC coverage before booking a visit.

Next Steps for South Dakota Patients

If you have a confirmed diagnosis of type 2 diabetes, heart failure with reduced ejection fraction, or CKD and want to start Farxiga, the fastest path is to order labs today, schedule a telehealth visit for when results return (typically 24 to 48 hours later), and send the prescription directly to your preferred South Dakota pharmacy or mail-order service.

Patients with South Dakota Medicaid should ask their prescriber about step-therapy alternatives such as empagliflozin (Jardiance), which may have different formulary status, or apply for the AstraZeneca AZ&Me program. Per the DAPA-HF trial, delaying SGLT2 inhibitor therapy in heart failure with reduced ejection fraction carries a measurable mortality cost: 16.3% of placebo patients experienced worsening heart failure or cardiovascular death over a median 18.2-month follow-up, compared with 11.8% in the dapagliflozin group [2].